Advancing Bioengineering and Industry Collaboration
Dublin Core
Title
Advancing Bioengineering and Industry Collaboration
Description
The Biomatrix Research Center, established at the NYU Polytechnic School of Engineering and generously supported by a $4.5 million grant from the Endre A. Balazs Foundation, marks a significant stride towards advancing bioengineering research with a keen focus on hyaluronan—a crucial polysaccharide in vertebrate biomatrix. Located in the burgeoning Health Corridor of Manhattan, the center not only capitalizes on its geographical advantage but also fosters a dynamic collaboration across various NYU schools, including the School of Medicine and the College of Nursing.
The research at the Biomatrix Research Center is spearheaded by Mary Cowman, an esteemed biochemist renowned for her work with hyaluronan. The center continues the pioneering efforts of the Matrix Biology Institute, founded by Drs. Endre Balazs and Janet Denlinger, to delve into the structural and functional properties of cellular matrices and explore their medical applications. Their work, particularly in the therapeutic uses of hyaluronan, has historical roots going back to the 1930s when it was first extracted from bovine eyes and later, more feasibly, from rooster combs by Balazs.
Hyaluronan has been instrumental in various medical treatments, including arthritis symptom management and ocular protection during surgeries. However, its potential extends far beyond these applications. The Biomatrix Research Center is poised to explore its capability in controlling cancer progression, enhancing wound healing, and repairing tissue damage, thereby bridging innovative research with real-world medical solutions.
The integration of the Biomatrix Research Center within NYU not only promotes multidisciplinary research but also establishes a robust connection with the industry. This relationship is critical as it enables the translation of laboratory breakthroughs into viable medical innovations, thus enhancing patient care and therapeutic techniques. The center’s position in Manhattan’s Health Corridor further facilitates partnerships with biotech and pharmaceutical companies, leveraging NYU’s historical strengths in entrepreneurship and innovation to push the boundaries of bioengineering and healthcare.
This strategic alignment with the industry is exemplified during the center’s grand opening, attended by notable figures from both the academic and industrial sectors. The enthusiasm for hyaluronan’s potential expressed by attendees underscores the center's role as a pivotal player in translating scientific research into industrial applications, thus maintaining NYU’s legacy of fostering innovation that benefits society at large.
The research at the Biomatrix Research Center is spearheaded by Mary Cowman, an esteemed biochemist renowned for her work with hyaluronan. The center continues the pioneering efforts of the Matrix Biology Institute, founded by Drs. Endre Balazs and Janet Denlinger, to delve into the structural and functional properties of cellular matrices and explore their medical applications. Their work, particularly in the therapeutic uses of hyaluronan, has historical roots going back to the 1930s when it was first extracted from bovine eyes and later, more feasibly, from rooster combs by Balazs.
Hyaluronan has been instrumental in various medical treatments, including arthritis symptom management and ocular protection during surgeries. However, its potential extends far beyond these applications. The Biomatrix Research Center is poised to explore its capability in controlling cancer progression, enhancing wound healing, and repairing tissue damage, thereby bridging innovative research with real-world medical solutions.
The integration of the Biomatrix Research Center within NYU not only promotes multidisciplinary research but also establishes a robust connection with the industry. This relationship is critical as it enables the translation of laboratory breakthroughs into viable medical innovations, thus enhancing patient care and therapeutic techniques. The center’s position in Manhattan’s Health Corridor further facilitates partnerships with biotech and pharmaceutical companies, leveraging NYU’s historical strengths in entrepreneurship and innovation to push the boundaries of bioengineering and healthcare.
This strategic alignment with the industry is exemplified during the center’s grand opening, attended by notable figures from both the academic and industrial sectors. The enthusiasm for hyaluronan’s potential expressed by attendees underscores the center's role as a pivotal player in translating scientific research into industrial applications, thus maintaining NYU’s legacy of fostering innovation that benefits society at large.
Creator
NYU Tandon
Publisher
NYU Tandon
Date
FEBRUARY 25, 2015
Contributor
N/A
Format
Website
Website Item Type Metadata
Local URL
https://engineering.nyu.edu/news/nyu-new-biomatrix-centers-key-halting-cancer-healing-wounds-hyaluronan
Files
Citation
NYU Tandon, “Advancing Bioengineering and Industry Collaboration,” Poly Archives, accessed March 3, 2026, https://www.polyarchives.hosting.nyu.edu/items/show/711.